Xia Mao - Concepedia

Author

Xia Mao

Huazhong University of Science and Technology ORCID

Also Known As

Jia Gu, Liting Chen, X H Mao, X Mao, X. Mao, XIA MAO, Xia Mao, Xia Nx Mao, Xiaojing Mao, Xinwen Mao

105

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Huazhong University of Science and Technology Tongji Hospital Hubei Provincial Center for Disease Control and Prevention Wuhan University of Science and Technology Wuhan Institute of Bioengineering

About

Xia Mao is an author at Huazhong University of Science and Technology specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	328
2	Health Sciences	3	3	40
3	Public Health	1	1	37
4	Biochemistry	1	1	12
5	Blood Transplantation	1	1	17

Xia Mao

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies Na Wang, Xuelian Hu, Wenyue Cao, Blood	2019	256
Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia Liang Huang, Dan Liu, Na Wang, Cell Research Jak/stat-myc-biosynthesis AxisHematological MalignancyFunctional GenomicsGenomic Analysis IdentifiesMixed-phenotype Acute Leukemia	2017	96
Inflammatory signatures for quick diagnosis of life-threatening infection during the CAR T-cell therapy Hui Luo, Na Wang, Liang Huang, Journal for ImmunoTherapy of Cancer	2019	70
A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia Chunrui Li, Wenyue Cao, Yimei Que, Clinical and Translational Medicine	2021	68
CD19/CD22 Chimeric Antigen Receptor T Cell Cocktail Therapy following Autologous Transplantation in Patients with Relapsed/Refractory Aggressive B Cell Lymphomas Yang Cao, Yi Xiao, Na Wang, Transplantation and Cellular Therapy	2021	63
Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma Jinhuan Xu, Qiuxiang Wang, Hao Xu, Journal of Hematology & Oncology	2018	61
Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for the treatment of diffuse large B-cell lymphoma Jia Wei, Xiaojian Zhu, Xia Mao, Journal for ImmunoTherapy of Cancer	2019	60
T Cells Expressing Anti B-Cell Maturation Antigen Chimeric Antigen Receptors for Plasma Cell Malignancies Chunrui Li, Qiuxiang Wang, Hui Zhu, Blood	2018	44
Intranasal immunization with heat shock protein 60 induces CD4+CD25+GARP+ and type 1 regulatory T cells and inhibits early atherosclerosis Y. Zhong, Hongxia Tang, Xiaolin Wang, Clinical & Experimental Immunology	2015	41
Efficacy and Safety of Fully Human Bcma Targeting CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma Chunrui Li, Jue Wang, Di Wang, Blood	2019	39

Page 1